Successful Initial Market Release of SomnoDent G2
SomnoMed Inc has completed a successful initial release of its next generation sleep apnea device, SomnoDent G2, in North America.
Read MoreSomnoMed Inc has completed a successful initial release of its next generation sleep apnea device, SomnoDent G2, in North America.
Read MoreRespire Medical continues to find growth in the fabrication of oral appliances used in the dental treatment of snoring and sleep apnea.
Read MoreRespicardia, a developer of implantable therapies to improve respiratory health, has appointed world-renowned cardiologist, Dr William T. Abraham, and seasoned medical device industry executive, Scott R. Ward, to its Board of Directors.
Read MoreThe second version release has been enhanced to more efficiently screen, electronically refer, and statistically track patients with sleep disorders in a primary care practice.
Read MorePhysician income increased modestly in 2012, with slightly higher percentages of doctors reporting incomes in the highest brackets.
Read More